In the 1990s, which development allowed the analysis of large populations using molecular techniques?

Prepare for your Epidemiology Test with our engaging content, including flashcards and multiple choice questions. Each question is accompanied by hints and explanations. Boost your readiness and confidence now!

Multiple Choice

In the 1990s, which development allowed the analysis of large populations using molecular techniques?

Explanation:
During the 1990s, the key change was applying molecular biology techniques to study large groups of people. Advances like PCR and later high-throughput genotyping made it feasible to gather and analyze genetic data from thousands or more individuals, turning molecular analysis into a population-level tool. This shift allowed researchers to look for associations between genetic variation and diseases across big cohorts, something not possible with earlier, smaller-scale studies. Other options don’t capture this shift. GIS-based analyses focus on spatial and environmental data rather than molecular data. Cloud-based storage and computing, while important today, were not the driver for enabling large-scale molecular analyses in that era. Expansion of randomization in clinical trials relates to study design and bias control, not the adoption of molecular techniques for analyzing large populations.

During the 1990s, the key change was applying molecular biology techniques to study large groups of people. Advances like PCR and later high-throughput genotyping made it feasible to gather and analyze genetic data from thousands or more individuals, turning molecular analysis into a population-level tool. This shift allowed researchers to look for associations between genetic variation and diseases across big cohorts, something not possible with earlier, smaller-scale studies.

Other options don’t capture this shift. GIS-based analyses focus on spatial and environmental data rather than molecular data. Cloud-based storage and computing, while important today, were not the driver for enabling large-scale molecular analyses in that era. Expansion of randomization in clinical trials relates to study design and bias control, not the adoption of molecular techniques for analyzing large populations.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy